uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Expression of Genes Encoding for Drug Metabolising Cytochrome P450 Enzymes and P-glycoprotein in the Rat Small Intestine: Comparison to the Liver
Uppsala University, Medicinska vetenskapsområdet, Faculty of Pharmacy, Department of Pharmaceutical Biosciences, Pharmaceutical Biochemistry.
2003 In: Eur. J. Drug Metab. Pharmacokin., Vol. 28, no 1, 41-48 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2003. Vol. 28, no 1, 41-48 p.
Identifiers
URN: urn:nbn:se:uu:diva-90892OAI: oai:DiVA.org:uu-90892DiVA: diva2:163405
Available from: 2003-10-01 Created: 2003-10-01Bibliographically approved
In thesis
1. Expression of Genes Encoding for Drug Metabolism in the Small Intestine
Open this publication in new window or tab >>Expression of Genes Encoding for Drug Metabolism in the Small Intestine
2003 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

This investigation focused on the mRNA expression of drug metabolising Cytochromes P-450 (CYP) and UDP-glucuronosyltransferases (UGT) and the transport protein P-glycoprotein (Pgp) in the small intestine of humans and rats.

The mRNA expression of the investigated genes in the human small intestine (duodenum) varies between individuals giving each one of us personal profile. In general, the most dominant forms are Pgp, CYPs 2C9, 2D6, 3A4, and UGTs 1A1, 1A10, 2B7. However, which of these is the highest expressed one varies between individuals.

The correlation in expression between some CYP forms and UGT forms respectively is relatively high, which indicates that they have some regulatory mechanisms in common. It was also shown that the mRNA expression of both CYPs and UGTs may be affected by endogenous and exogenous factors. Sex and ethnic background, affected the mRNA expression of CYP2A6 and 2E1 respectively. Commonly used drugs such as acetylsalicylicacid (ASA) and omeprazole (omep) affect CYP2A6, CYP2E1 (ASA) and CYP3A4, UGT1A4 (omep). The expression of UGT1A4 is also affected by smoking. All these factors are commonly used and can therefore lead to important drug-drug interactions.

It was also shown that the human small intestinal CYP mRNA expression pattern differs from that found in the rat. The rat CYP expression is rather constant between the different individuals, and the main rat intestinal forms are CYP1A1, CYP2C, CYP2D6 and CYP3A1. The expression is the same for females and males and no difference can be seen between the different segments of the rat small intestine. As metabolic studies have often been done with rat liver we compared the mRNA expression in the two organs. We found that the mRNA expression of 1A1 was absent in the liver and that the CYP2B1, CYP2Cs, CYP2D1 and Pgp all had a stronger mRNA expression in the small intestine compared to the liver. It is therefore important to realise that results from metabolic studies on liver may not be directly extrapolated to the small intestine.

Artemisinin is an orally used drug in multidrug treatment of malaria in Southeast Asia. It has been suggested that artemisinin can induce drug metabolism and therefore be involved in drug-drug interactions. This study shows that artemisinin induces mainly the CYP2B via nuclear receptor CAR.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2003. 45 p.
Series
Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy, ISSN 0282-7484 ; 297
Keyword
Pharmaceutical biochemistry, CYPs, UGTs, interindividual variation, small intestine, human, rat, artemisinin, CAR-receptor regulation, Farmaceutisk biokemi
National Category
Pharmaceutical Sciences
Identifiers
urn:nbn:se:uu:diva-3601 (URN)91-554-5753-3 (ISBN)
Public defence
2003-10-24, C8:305, BMC, Uppsala, 09:15
Opponent
Supervisors
Available from: 2003-10-01 Created: 2003-10-01Bibliographically approved

Open Access in DiVA

No full text

By organisation
Pharmaceutical Biochemistry

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 365 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf